Site Under Construction

Cutaneous Rosai-Dorfman disease in a 40-year-old female: A case report

Joland A. San Juan, MD, Juan Antonio D. Cervantes, MD, Johannes F. Dayrit, MD, FPDS, FDSP, Ricky H. Hipolito, MD, FPDS, Ma. Teresita G. Gabriel, MD, FPDS



Rosai-Dorfman disease is a rare disease that manifests with painless cervical lymphadenopathy, fever, anemia, an elevated erythrocyte sedimentation rate (ESR), and hypergammaglobulinemia. Extranodal lesions occur in 1/3 of patients, and the skin is involved in more than 10% of cases. Purely cutaneous disease is uncommon and only about more than 100 cases have been reported. Cutaneous Rosai-Dorfman Disease (CRDD) appears to be a distinct entity with different age and race predilection from cases with lymph node involvement.


Case Report

This is a case of a 40-year-old Filipino female who presented with multiple erythematous papules and plaques with pustules on the cheeks. Skin punch biopsy showed a dense dermal infiltrate of polygonal histiocytes with abundant cytoplasm and vesicular nuclei. Emperipolesis was also present. The histiocytes were highlighted by the immunohistochemical stains S-100 and CD68 and was CD1a negative. Complete blood count and ESR were normal. Cervical lymphadenopathy was absent. Findings were consistent with Cutaneous Rosai-Dorfman disease. The patient was started on methotrexate at 15mg/week with folic acid supplementation. Mild soap, benzoyl peroxide 5% gel and tretinoin 0.05% cream once daily were maintained during the treatment course. There was significant decrease in erythema and size of existing lesions after 2 months. The patient was referred to a hematologist for monitoring of possible future systemic involvement.



Because of its rarity, clinicopathological correlation is always mandatory to establish a diagnosis of CRDD. Immu nohistochemical stains are required to differentiate this entity form other forms of Langerhans cell histiocytosis. Multidisciplinary referral is required to rule out concomitant systemic involvement.


  1. Kang, S., Amagai M., Bruckner AL., Enk AH., Margolis DJ., McMichael AJ., Orringer JS. Fitzpatrick’s Dermatology 9th edition. McGraw-Hill Education; 2018 p. 2031.
  2. Frater, J. L., Maddox, J. S., Obadiah, J. M., & Hurley, M. Y. Cutaneous Rosai-Dorfman Disease: Comprehensive Review of Cases Reported in the Medical Literature since 1990 and Presentation of an Illustrative Case. Journal of Cutaneous Medicine and Surgery. 2006; 10(6), 281–290. DOI: 10.2310/7750.2006.00067.
  3. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol 1990;7:19–73.
  4. Brenn, T., Calonje, E., Granter, S. R., Leonard, N., Grayson, W., Fletcher, C. D. M., & McKee, P.H. Cutaneous Rosai-Dorfman Disease Is a Distinct  Clinical Entity. The American Journal of Dermatopathology. 2002, 24(5), 385–391. DOI: 10.1097/01.DAD.0000026462.55673.41. 5. J.L. Bolognia, J.L. Jorizzo, J.V. Schaffer Dermatology. 3rd Edition. Elsevier Saunders, Philadelphia (2012), pp. 1441-1443.
  5. G. Kroumpouzos, M.F. Demierre Cutaneous Rosai-Dorfman disease: histopathological presentation as inflammatory pseudotumor. A  literature review Acta Dermato-Venereol. 2002, 82 (4), pp. 292- 296. DOI: 10.1080/000155502320323289
  6. Pulsoni A, Anghel G, Falcucci P, Matera R, Pescarmona E, Ribersani M, et. al. Treatment of sinus histiocytosis with massive lymphadenopathy  (Rosai-Dorfman disease): report of a case and literature review. Am J Hematol. 2002; 69(1):67-71. DOI: 10.1002/ajh.10008.
  7. Nasseri E, Belisle A, Funaro D. Rosai-Dorfman disease treated with methotrexate and low-dose prednisone: case report and review of the literature. J Cutan Med Surg. 2012;16(4):281-285.DOI: 10.1177/120347541201600411.
  8. Sun NZ, Galvin J, Cooper KD. Cutaneous Rosai-Dorfman Disease Successfully Treated With Low-Dose Methotrexate. JAMA Dermatol.  2014;150(7):787–788. DOI:10.1001/jamadermatol.2013.8679.
  9. Matin T, Goodman MB. Benzoyl Peroxide. [Updated 2020 Nov 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-.  Available from:

REquesting Permission

Cutaneous Rosai-Dorfman disease in a 40-year-old female: A case report